CF9600 Automatic Hematology Analyzer

CF9600 Automatic Hematology Analyzer

Cell Counters

Information

1. One tube of blood, one minute to complete a 6-parameter combined test, offering 38 combinatorial modes and generating 42 reportable parameters. 2. Integrates three core technologies—nucleic acid fluorescent staining, laser scatter, and sheath flow impedance—to ensure highly reliable results. 3. The dedicated WPC and PLT-F channels, combined with our proprietary self-developed stain, enable precise identification of abnormal samples. 4. Supports automatic capillary blood sampling, featuring an innovative auto-rotational mixing function to eliminate manual errors and ensure sample homogeneity.
Shenzhen CoooSeee Biomedical Co., Ltd.H3.A30CoooSeee Biomedical, a subsidiary of Comen Group, specializes in the in vitro diagnostics (IVD) field. We are committed to providing global users with high-performance IVD medical instruments and consumables. Our products, including hematology analyzers, specific protein analyzers, hematology automation line, demonstrating strong technological competitiveness and strengthening our industry position in the in-vitro diagnostics market. Beyond existing business domains, we continue to intensify R&D investment and technological innovation in biochemistry, chemiluminescence,and coagulation testing, delivering comprehensive integrated laboratory solutions globally. Comen Group, a clinician-focused R&D enterprise headquartered in Shenzhen, has continually advanced in life supporting systems, medical imaging and healthcare informatics since its founding in 2002, while expanding into IVD and surgical solutions. With 40+ global subsidiaries, we serve 270,000 hospitals and medical institutions across 190+ countries and regions. Leveraging Comen Group's mature R&D infrastructure and production expertise in medical devices, CoooSeee Biomedical integrates product development, manufacturing, market services and corporate management resources to accelerate our evolution into a world-class medical device enterprise. Furthermore, Comen Group s 20+ years of accumulated user and channel partnerships will serve as strategic assets for CoooSeee Biomedical, collectively advancing the global healthcare ecosystem.

Log in

See all the content and easy-to-use features by logging in or registering!